Ayrton Capital’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Ayrton Capital’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150,000	Closed	-$2K	–	79
2023 Q2	$2K	Hold	150,000	–	–	0.01%	65
2023 Q1	$7.67K	Hold	150,000	–	–	0.03%	56
2022 Q4	$12.8K	Hold	150,000	–	–	0.03%	49
2022 Q3	$34K	Hold	150,000	–	–	0.06%	53
2022 Q2	$34K	Hold	150,000	–	–	0.06%	55
2022 Q1	$115K	Hold	150,000	–	–	0.15%	58
2021 Q4	$180K	Buy	+150,000	New	+$171K	0.17%	63

Ayrton Capital's GRNAW Position: Q3 2023 in Review

Ayrton Capital sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 150,000 shares — an estimated $2K sold.

Ayrton Capital first reported a position in GRNAW in Q4 2021 and held it in 7 quarters. The position peaked at $180K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Ayrton Capital reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Ayrton Capital sold 150,000 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $2K.
Ayrton Capital first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q4 2021 and held it in 7 quarters.
Ayrton Capital's GreenLight Biosciences Holdings, PBC Warrant position peaked at $180K in Q4 2021.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Ayrton Capital's 13F filing for Q3 2023, filed 13 Nov 2023.